Miller-Rich Nancy
Related Filers (4)
- INTERCEPT PHARMACEUTICALS, INC. (8)
- Aldeyra Therapeutics, Inc. (6)
- Kadmon Holdings, Inc. (4)
- 4D Molecular Therapeutics, Inc. (4)
- Show More ...
Ownership (22)
4
Monday, 11/13/2023
INTERCEPT PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Aldeyra Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/25/2023
4D Molecular Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/25/2023
INTERCEPT PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/9/2022
Aldeyra Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
INTERCEPT PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/25/2022
4D Molecular Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/9/2021
Kadmon Holdings, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/10/2021
Aldeyra Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/1/2021
INTERCEPT PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/19/2021
4D Molecular Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/13/2021
Kadmon Holdings, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/10/2020
4D Molecular Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 8/13/2020
Kadmon Holdings, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/13/2020
Kadmon Holdings, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/11/2020
Aldeyra Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/1/2020
INTERCEPT PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/15/2020
Aldeyra Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 1/15/2020
Aldeyra Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/21/2019
INTERCEPT PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/22/2018
INTERCEPT PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 4/25/2018
INTERCEPT PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities